The present study aimed to determine the effect of a green tea supplement on anthropometric indices and inflammatory factors in women with polycystic ovary syndrome (PCOS). In this randomized clinical trial, 45 women with PCOS were randomly allocated into two groups receiving green tea tablets or placebo. The period of intervention was 45 days. The serum levels of interleukin 6, high-sensitivity C-reactive protein, and tumor necrosis factor α were measured before and after intervention period using the related kits. Anthropometric indices also were measured. The mean of body mass index, weight, waist circumference, and body fat percentage in the green tea group were reduced significantly. However, no significant difference was observed between the two groups. Also, there was no significant effect on the levels of inflammatory factors. The present results suggest that daily consumption of green tea tablets did not cause any effect on inflammation biomarkers in PCOS women. However, it may be effective as a complementary treatment for weight control in these women. Copyright
INTRODUCTION
Polycystic ovary syndrome (PCOS), which affects 6-25% of women before menopause, is one of the most common endocrine disorders in women of reproductive age that can affect multiple systems in the body (Varghese, 2014) . Irregular menstrual cycles, infertility, hirsutism, acne, thinning of scalp hair, insulin resistance, and obesity are common manifestations of this syndrome (Nagarathna et al., 2014) . Chronic anovulation, hyperandrogenism, and polycystic ovaries detected on ultrasound are three key diagnostic characteristics of PCOS. Like most complex heterogeneous diseases, both genetic and environmental factors are implicated, but the exact etiology of PCOS is still unknown (Norman et al., 2007) .
Overweight or obesity has been found in a large proportion of women with PCOS (Lim et al., 2013) . Excess body weight, which is a factor in PCOS etiology, has an aggravating effect on metabolic and reproductive disorders in women with this syndrome (Norman et al., 2007; Teede et al., 2010) such as insulin resistance, dyslipidemia, infertility, and hyperandrogenism (Lim et al., 2013) . Insulin resistance is also a participating factor in the pathophysiology of this syndrome, causing an increase in free androgen by reducing sex hormone binding globulin and exacerbating androgen production, which contributes to metabolic and reproductive features (Teede et al., 2010) .
A state of chronic low-grade inflammation presents in patients with PCOS, which might be responsible for the long-term metabolic effects and cardiovascular complications in this syndrome (Ebejer and CallejaAgius, 2013) . It seems that the inflammation associated with PCOS may be due to one or more metabolic disorders (such as obesity or insulin resistance) rather than an inherent result of the syndrome, when metabolic factors such as body mass index (BMI), fat distribution, and insulin sensitivity are controlled (Sirmans et al., 2012) . However, some studies suggest an inflammatory condition intrinsic to PCOS, according to the lower level of inflammation in the high-BMI non-PCOS women compared with the high-BMI PCOS women (Ebejer and Calleja-Agius, 2013) . Many studies have shown that women with this syndrome have significantly higher serum levels of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6), when compared with controls (Ebejer and Calleja-Agius, 2013) . C-reactive protein, which can predict an increased risk of coronary heart disease and cardiovascular events, is produced by the liver following stimulation by IL-6 and also directly by adipose tissue (González, 2012) . Tumor necrosis factor α and IL-6 can induce insulin resistance, which can stimulate androgen production (Xiong et al., 2011) , anovulation (Ebejer and Calleja-Agius, 2013) , and several disorders associated with insulin resistance including type 2 diabetes, hypertension, endothelial dysfunction, and heart disease (Sathyapalan and Atkin, 2010) .
Consumption of tea is popular worldwide. Green, black, and Oolong teas are three types of tea, derived from the plant Camellia sinensis L. Among all of these, green tea has the most significant effects on human health (Chacko et al., 2010) . The major contribution of the health-promoting effects of green tea is associated with its polyphenol content (Sano et al., 2001) . Enhancement of immune system function (Khan et al., 2016) , antibacterial activity (Di Vito et al., 2015) , antineoplastic (Fujiki et al., 2015; Pedro et al., 2016) , anti-inflammatory (Dona et al., 2003) , antioxidative (Osada et al., 2001) , antihyperlipidemic potentials (Raederstorff et al., 2003; Mahmoud et al., 2016) , and protective effect over cardiovascular disease (Sueoka et al., 2001 ) are some of the health benefits of consuming green tea. Also green tea has been considered as a thermogenic plant for weight loss (Stohs and Badmaev, 2016) . Protective effects of tea against many diseases associated with chronic inflammation have been shown by many epidemiological and laboratory studies (Sirmans et al., 2012) .
Given that an inflammatory condition can lead to complications such as insulin resistance, endothelial dysfunction, and cardiovascular diseases (the main cause of death in the world) and considering that improvements in metabolic and endocrine disorders and menstrual cycle and ovulation regulation are observed with weight loss, the aim of the current study was to investigate the impact of green tea supplementation on inflammatory factors and anthropometric measurements in women suffering from PCOS.
MATERIALS AND METHODS
Fifty patients with PCOS, screened from a gynecology clinic, were enrolled. Inclusion criteria were as follows: age range 18-55 years, BMI range 20-35 kg/m 2 , and proven diagnosis of PCOS according to guidelines set by the Rotterdam criteria (Rotterdam ESHRE/ ASRM-Sponsored PCOS Consensus Workshop Group, 2004) , which requires the presence of two of three features: clinical and/or biochemical hyperandrogenism, oligomenorrhea/amenorrhea, or presence of 12 or more follicles less than 10 mm in each ovary and/or increased ovarian volume ( 10 mL) diagnosed by ultrasound. Exclusion criteria were as follows: pregnant or lactating women; patients diagnosed with hypertension, renal dysfunction, liver disease, adrenal or thyroid dysfunction, Cushing's syndrome, or heart disease; or patients with a history of stroke.
Sample size. The sample size was designed with 95% confidence and 80% power with an estimated standard deviation and difference of hs-CRP between groups, so at least 22 cases were needed in each group. According to a possible withdrawal of 10% of patients during the study, 25 patients were enrolled in each group.
Subjects and study design. This study was a randomized double-blind placebo-controlled trial in which patients were randomly (block design) allocated into either the green tea group (intervention, n = 25) or the placebo group (control, n = 25). The intervention group received four tablets of green tea (Green Teadin, Dineh Co., Tehran, Iran) containing 500-mg green tea (C. sinensis L.) leaf powder. The placebo group received the same number of placebo tablets (corn starch) for 45 days. There were no co-interventions. The researchers were blinded to the type of supplement given to each patient. A third party kept the identities of the subjects and which group (green tea or placebo) they belong to, which were not revealed to researchers until the end of study. Patients were matched for age, socioeconomic status, physical activity levels, and medications in two groups. At the beginning of the study and after 45 days of intervention, anthropometric indices were measured and blood samples were obtained from each participant. A 24-h dietary recall questionnaire (two work days and one weekend) was also completed to determine the dietary intakes of each woman and to assess any changes in the dietary pattern. Dietary intake was analyzed using Nutritionist 4. Dietary advice was given to all participants. Both groups were asked to maintain their usual dietary pattern and physical activity level during the study, and they were instructed not to consume any beverages or food containing polyphenols, except to the amounts that the researcher has determined. For the determination of a subject's activity level, an international physical activity questionnaire was used. The subjects were given supplements weekly and were contacted two times a week by telephone or short message service to ensure that they were using prescribed tablets. Also, they were asked to bring their tablet package every week to monitor compliance by counting the number of remaining tablets. If they consumed less than 80% of the tablets, they were excluded. During the period of study, two participants withdrew for reasons of digestive complications and three due to pregnancy. Forty-five patients completed the study (intervention group: n = 22, placebo group: n = 23). The flowchart of the study has been presented in Fig. 1 , and Table 1 shows key information about the study.
Ethics. The study was approved by the Ethics committee of Ahvaz Jundishapur University of Medical Sciences (ID: AJUMS.rec.1393.406), and all patients completed an informed consent form. The study was registered in the Iranian Registry of Clinical Trials (IRCT), available at http://www.irct.ir (ID: IRCT201502186123N4).
Anthropometric assessments. Height and weight were recorded with an accuracy of 0.1 kg and 0.1 cm, respectively. Body mass index was calculated based on the following formula: bodyweight in kilograms divided by height in meters squared. An inflexible measuring tape was used to determine waist circumference (WC) and hip circumference (HC) with an accuracy of 0.1 cm. The HC was measured at its maximum over the buttocks, the WC was measured in place of the smallest circumference between the rib margin and the iliac crest, and the waist-to-hip ratio was calculated by dividing WC to HC. Body fat percentage was calculated using Deurenberg's formula (Deurenberg et al., 1991) .
Measurement of inflammatory markers. At the beginning of the study and after the intervention period, blood samples were collected after 12 h of fasting. Samples were placed at room temperature for half an hour and then for 5 min at 37°C bain-marie. The samples were centrifuged at 3000 rpm for 5 min. Blood serum was isolated and stored at 80°C for later assessment. Tumor necrosis factor α and IL-6 serum levels were measured using the enzyme-linked immunosorbent assay method with highly sensitive kits (sensitivity was 0.92 and 0.13 pg/mL for IL-6 and TNF-α, respectively) (Bender Med-system, Biocenter, Vienna, Austria). Levels of hs-CRP were measured by immunoturbidimetric assay (Bionik Diagnostic System, Tehran, Iran).
Statistical analysis. Data were analyzed using SPSS software (version 16.0, SPSS Inc, Chicago, IL, USA). For us to examine differences within each group at baseline and after 45 days, paired t-tests were used, and the independent t-test was used for comparison between two groups. A Pearson correlation test was used to show the relationship between two quantitative variables. A p-value <0.05 was considered significant, and data were reported as means ± SDs. Intention-to-treat analysis was not used. Fig. 1 shows the flowchart of the study. From 50 patients who were entered in the study, five subjects withdrew because of some reasons, that is, gastrointestinal complications and being pregnant, so the data were reported for 45 patients (22 in the green tea group, 23 in the placebo group).
RESULTS

Baseline characteristics
As Table 2 shows, the Bakhtiari ethnic group had the greatest number of patients in each group, and the minimum of them were Arab, but there was no significant difference between the two groups. In terms of education level, it was not statistically significant between the two groups. None of the patients followed a special diet. Most of the patients in both groups had low physical activity, and none of them have had healthenhancing physical activity. Similar to the demographic characteristics, there was no significant difference between the two groups for activity level.
Dietary intake
According to Table 3 , there was no significant difference between the two groups or within each group before and after the intervention period in terms of macronutrient and micronutrient intakes. However, in the placebo group, a significant difference for vitamin C intake was observed compared with pre-intervention. Also, a significant difference was observed between the two groups in terms of fat intake at baseline. The effects of them were removed by analysis of covariance.
Anthropometric measurements
The mean (±SD) of anthropometric measurements before and after the intervention period are shown in Table 4 . There were no differences in age, height, weight, BMI, WC, HC, waist-to-hip ratio, or body fat between green tea and placebo groups at baseline and after intervention. Although weight, BMI, WC, and body fat percentage decreased in both groups after 45 days, a significant reduction was observed only in the green tea group (Table 4) .
Measurement of inflammatory markers
Levels of inflammatory factors are shown in Table 5 for both groups before and after intervention. There were no significant differences between the two groups or in either group before and after the intervention period, in terms of TNF-α, IL-6, and hs-CRP.
Correlation of interleukin 6 level with anthropometric indices
A significant positive correlation between reduced levels of IL-6 by reduction of the body weight, BMI, waist circumference, hip circumference, and body fat percentage was observed only in the green tea group after the intervention; correlation coefficient and the significance level are given in Table 6 . This finding demonstrates that after intervention, only in the green tea group, along with decreases in anthropometric indices, IL-6 levels also declined. 
Adverse effect
In this study, except two cases of gastrointestinal complications, no other complications were reported.
DISCUSSION
This study was a double-blind randomized clinical trial in which 45 women with PCOS consumed four tablets of green tea (n = 22) or placebo (n = 23) for a period of 45 days to evaluate the effect of green tea supplementation on anthropometric indices and inflammatory factors. The results of this study showed that green tea supplement caused a significant reduction in weight, BMI, WC, and body fat percentage after the intervention period in the green tea group, but no significant difference was observed between the two groups. Many studies have examined the effects of green tea on anthropometric indices. Some of them indicated an association between green tea intake and weight control. Allahdadian et al. (2015) reported that green tea consumption (capsule 500 mg, two times a day for 12 weeks) resulted in a significant weight loss in overweight and obese patients with PCOS, which is in accordance with our result. The only difference with our study is that in Allahdadian's study, there was a significant difference between the two groups, which may be due to the prolonged intervention period compared with our study. Also, similar to the present findings, epigallocatechin gallate (the major polyphenol component of green tea) supplementation (300 mg/day for 12 weeks) led to a significant reduction in body weight, BMI, body fat mass, and WC in obese women in both intervention and control groups, but there was no significant difference between the groups (Mielgo-Ayuso et al., 2014) .
In contrast to our study, Chan et al. (2006) reported that 3 months' supplementation with six capsules of green tea per day containing 540-mg epigallocatechin gallate did not show significant weight loss in obese individuals with PCOS. Consumption of three capsules of green tea extract per day for 12 weeks also did not show a significant decrease in body weight, BMI, or body fat percentage in obese women, but waist circumference was significantly reduced in the green tea group, which is consistent with our result (Zolfaghary et al., 2013) . There are a number of possible reasons for inconsistent results after dietary intervention, including difference in green tea dosage, contents of green tea flavonoids, and timing and method of green tea consumption (supplement, beverage, etc.).
Weight loss mechanism induced by green tea may be explained by catechin polyphenol and caffeine contents of green tea, which leads to prolonged action of catecholamines (Chan et al., 2006 (Chan et al., , 2013 Paknahad et al., 2012; Rains et al., 2011; Stohs and Badmaev, 2016) and increased levels of norepinephrine. This will lead to increased energy expenditure and fat oxidation (Diepvens et al., 2005; Chan et al., 2006; Auvichayapat et al., 2008; Rains et al., 2011; Paknahad et al., 2012) . Other mechanisms include decreased appetite (Diepvens et al., 2005;  Auvichayapat et al., 2008) , reducing the absorption of nutrients such as glucose by inhibition of α-amylase and α-glucosidase and inhibition of glucose uptake in the intestine cells (Matsumoto et al., 1993; Johnston et al., 2005) and inhibition of intestinal absorption of dietary lipids by catechin (Sarani Ali Abadi et al., 2013) . Recent evidence suggests a condition of low-grade chronic inflammation in PCOS that could be a potential cause of long-term complications of the syndrome such as cardiovascular disease (Repaci et al., 2011) . To the best of our knowledge, the present study is the first to examine the effect of green tea supplementation on inflammatory factors in women suffering from PCOS. Comparison between and within groups in our study indicated no significant difference in the levels of IL-6, TNF-α, and hs-CRP after 45 days of supplementation.
Green tea and green tea catechins have been shown to influence plasma levels of inflammation markers in several diseases that related to inflammation (Stote et al., 2012; Uchiyama et al., 2013; Fukuzawa et al., 2014) . Ghafurniyan et al. (2014) showed that intraperitoneal injection of green tea extract in Wistar rats with PCOS, caused significant reduction in CRP and IL-6 levels after 14 days, but this finding is not consistent with our results; however, this was an animal study. Also, Zolfaghary et al. (2013) indicated that consumption of green tea extract (three-capsule extract for 12 weeks) led to significant reduction in CRP levels in obese women, which does not match with our study, and it was probably a result of the longer intervention period compared with our study. Our results confirm the study by Basu et al. (2011) in which green tea beverage or extract supplementation for 8 weeks did not significantly alter the biomarkers of inflammation IL-6 and hs-CRP. Similarly, Mielgo-Ayuso et al. (2014) did not find any significant change in hs-CRP levels after 12 weeks of supplementation with 300-mg/day epigallocatechin gallate (a powerful antioxidant in green tea) in obese pre-menopausal women, and no changes were seen in IL-6 and hs-CRP levels in subjects with type 2 diabetes following green tea intervention for 4 weeks (Ryu et al., 2006) . One of the reasons for inconsistent results in this regard might be interactions with other competitive nutrients that alter bioavailability of catechins (Bøhn et al., 2012) ; flavonoids may be metabolized differently in healthy and disease-affected subjects (Peluso et al., 2013) .
Some studies revealed the inhibition of transcriptional factor, nuclear factor κB, by catechins mediated production of cytokines in endothelial and inflammatory cells and subsequent suppression of adhesion to endothelium and transmigration (Bogdanski et al., 2012) . In addition, a study showed that cytokines such as IL-1β and IL-6 are inhibited by tea polyphenols, which prevent them from coupling with their receptors and hinder them from signaling inflammatory cascades (de Mejia et al., 2009) .
We also found a significant correlation between IL-6 levels and BMI, waist circumference, hip circumference, weight, and body fat percentage in the green tea group after intervention. Given that the proinflammatory cytokine IL-6 is produced and secreted partly by adipose tissue (Tsilchorozidou et al., 2009) , and several studies indicated that elevated inflammatory factor levels in PCOS may be due to obesity rather than PCOS per se (Sirmans et al., 2012) , the significant reduction in IL-6 levels in the green tea group after the intervention was probably a result of the reduction in anthropometric indices.
Main strengths and weaknesses
To the best of our knowledge, this study was the first in which the effect of green tea on inflammatory cytokines was investigated among women with PCOS. The present study has a number of limitations. The study was only 45 days in duration, and thus, we only evaluated the short-term effect of green tea. Although the subjects were asked to maintain their usual physical activity and diet, our results are dependent on their compliance with this request.
Recent studies have shown that adverse events of medical plants are infrequent. In our study, except two cases of gastrointestinal complications, no other complications were reported. Also, herbal medicines may interact with some medications or nutrients. For example, green tea interferes with folic acid absorption and should be restricted during pregnancy (Izzo et al., 2016) .
CONCLUSIONS
This study indicated that green tea supplement intake may reduce anthropometric indices in PCOS women but does not alter the inflammatory factors in this syndrome. However, more clinical trials with higher dosage of green tea and longer study duration may be effective in decreasing elevated inflammatory factors in PCOS women.
